US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

308.33

-8.8700-2.80%

Post-market: 306.40-1.9300-0.63%17:02 EDT

Volume:353.51K

Turnover:107.32M

Market Cap:655.04M

PE:- -

High:315.40

Open:314.79

Low:293.00

Close:317.20

52wk High:341.93

52wk Low:66.60

Shares:2.12M

Float Shares:2.12M

Volume Ratio:0.70

T/O Rate:16.64%

Dividend:1.02

Dividend Rate:0.33%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

HC Wainwright Starts Theriva (TOVX) at Buy on Undervalued Oncolytic Virus Platform and Advancing VCN-01 Pancreatic Cancer Program

Acadia Healthcare (ACHC) Securities Lawsuit Moves Forward After Court Denies Dismissal Bid

Analysts Offer Insights on Healthcare Companies: NextCure (NXTC) and CalciMedica (CALC)

Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD)

Freenome Says It Has Obtained FDA Breakthrough Device Designation for Lung Cancer Screening Test

MT Newswires Live

FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N.V. (ATAI)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: AIM ImmunoTech (AIM) and Schrodinger (SDGR)

Analysts Offer Insights on Healthcare Companies: 908 Devices (MASS), Pediatrix Medical Group (MD) and BridgeBio Oncology Therapeutics (BBOT)

Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Maze Therapeutics, Inc. (MAZE) and Immunome (IMNM)

TransMedics Buy Rating Reaffirmed as Analyst Maintains $95 Price Target on Robust Multi-Year Growth Outlook

Press Release: PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Brookdale Senior Living (BKD) and Legend Biotech (LEGN)

Press Release: Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update

Drug Manufacturing Site of Shanghai Haoyuan Chemexpress Passes US FDA Inspection With Zero Deficiencies

Harmony Biosciences: Strengthening Core Business and Pipeline Support Unchanged $55 Price Target and Buy Rating

Regulatory Milestone: Subsidiary of Aurisco Pharmaceutical Passes U.S. FDA Inspection

LG Electronics Secures US FDA Clearance to Launch New Diagnostic Monitor

MT Newswires Live

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Tecan Group AG (OtherTCHBF), Kyverna Therapeutics, Inc. (KYTX) and Pliant Therapeutics (PLRX)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LABU/news?page=17"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":308.33,"timestamp":1787601600000,"preClose":317.2,"halted":0,"volume":353514,"hourTrading":{"tag":"盘后","latestPrice":306.4,"preClose":308.33,"latestTime":"17:02 EDT","volume":67,"amount":20656.508700000002,"timestamp":1787605332850,"change":-1.93,"changeRate":-0.00626,"amplitude":0.014724},"delay":0,"changeRate":-0.027963430012610355,"floatShares":2124486,"shares":2124486,"eps":0,"marketStatus":"Post-Mkt","change":-8.87,"latestTime":"08-24 17:15:18 EDT","open":314.79,"high":315.4,"low":293,"amount":107324146.0179,"amplitude":0.070618,"askPrice":311.2,"askSize":200,"bidPrice":306,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":317.2,"sharesOutstanding":3074486,"nav":316.946,"aum":673347221.03,"dividendRate":0.003292,"bidAskSpread":0.002803,"preHourTrading":{"tag":"盘前","latestPrice":314.59,"preClose":317.2,"latestTime":"09:25 EDT","volume":1055,"amount":335012.8868,"timestamp":1787577900633,"change":-2.61,"changeRate":-0.008228,"amplitude":0.020255},"postHourTrading":{"tag":"盘后","latestPrice":306.4,"preClose":308.33,"latestTime":"17:02 EDT","volume":67,"amount":20656.508700000002,"timestamp":1787605332850,"change":-1.93,"changeRate":-0.00626,"amplitude":0.014724},"volumeRatio":0.698191,"impliedVol":0.977,"impliedVolPercentile":0.757},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2124486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.698191,"shares":2124486,"dividePrice":1.015,"high":315.4,"amplitude":0.070618,"preClose":317.2,"low":293,"week52Low":66.6,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":308.33,"eps":0,"divideRate":0.003292,"volume":353514,"delay":0,"ttmEps":0,"open":314.79,"prevYearClose":159.39,"prevWeekClose":317.2,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":287.3,"twentyDayClose":246.27,"sixtyDayClose":191.66},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:17,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659041419","title":"HC Wainwright Starts Theriva (TOVX) at Buy on Undervalued Oncolytic Virus Platform and Advancing VCN-01 Pancreatic Cancer Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2659041419","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659041419?lang=en_us&edition=fundamental","pubTime":"2026-08-13 01:55","pubTimestamp":1786557343,"startTime":"0","endTime":"0","summary":"Theriva Biologics, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jason McCarthy from Maxim Group maintai...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/hc-wainwright-starts-theriva-tovx-at-buy-on-undervalued-oncolytic-virus-platform-and-advancing-vcn-01-pancreatic-cancer-program-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/hc-wainwright-starts-theriva-tovx-at-buy-on-undervalued-oncolytic-virus-platform-and-advancing-vcn-01-pancreatic-cancer-program-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","TOVX","LABU","BK4588","BK4585","XBI","BK4139","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659356904","title":"Acadia Healthcare (ACHC) Securities Lawsuit Moves Forward After Court Denies Dismissal Bid","url":"https://stock-news.laohu8.com/highlight/detail?id=2659356904","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659356904?lang=en_us&edition=fundamental","pubTime":"2026-08-13 01:30","pubTimestamp":1786555844,"startTime":"0","endTime":"0","summary":"Acadia Healthcare Company, Inc. (ACHC) will continue facing a federal securities lawsuit after a Tennessee federal judge denied the defendants’ mot...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/acadia-healthcare-achc-securities-lawsuit-moves-forward-after-court-denies-dismissal-bid?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/acadia-healthcare-achc-securities-lawsuit-moves-forward-after-court-denies-dismissal-bid?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","ACHC","XLV","BK4185","XBI","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659901648","title":"Analysts Offer Insights on Healthcare Companies: NextCure (NXTC) and CalciMedica (CALC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659901648","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659901648?lang=en_us&edition=fundamental","pubTime":"2026-08-13 01:00","pubTimestamp":1786554032,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on NextCure (NXTC) and CalciMedica (CALC). NextCure (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nextcure-nxtc-and-calcimedica-calc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nextcure-nxtc-and-calcimedica-calc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","CALC","BK4581","XLV","BK4137","BK4585","LU0029874061.USD","BK4139","HCSG","BK4007","XBI","NXTC","LU0128526141.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659901615","title":"Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659901615","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659901615?lang=en_us&edition=fundamental","pubTime":"2026-08-13 00:50","pubTimestamp":1786553410,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bionano-genomics-bngo-liquidia-technologies-lqda-and-polypid-pypd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bionano-genomics-bngo-liquidia-technologies-lqda-and-polypid-pypd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4575","XBI","BK4121","BK4588","LABU","LU0029874061.USD","LU0128526141.USD","BK4007","XLV","BK4137","BK4581","BNGO","BK4585","PYPD","LQDA","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658086839","title":"Freenome Says It Has Obtained FDA Breakthrough Device Designation for Lung Cancer Screening Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2658086839","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658086839?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:29","pubTimestamp":1786541387,"startTime":"0","endTime":"0","summary":"Freenome  has obtained breakthrough device designation for its investigational lung cancer screening test SimpleScreen Lung from the US Food and Drug Administration, the company said Wednesday.The designation applies to the proposed use of SimpleScreen Lung in adults aged 50 to 80 years who have at least a 20 pack-year smoking history and are currently participating in guideline-recommended lung cancer screening, according to a statement.Freenome said that the clinical evaluation of the test is ongoing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","FRNM","LABU","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658961908","title":"FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2658961908","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658961908?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:00","pubTimestamp":1786539600,"startTime":"0","endTime":"0","summary":"Investigational AI-powered multiomic test is being developed for adults ages 50-80 at high risk who are not currently participating in guideline-recommended lung cancer screeningBRISBANE, Calif., Aug.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/12/3343694/0/en/fda-grants-breakthrough-device-designation-to-freenome-s-blood-based-simplescreen-lung-cancer-screening-test.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658709499","title":"Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N.V. (ATAI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658709499","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658709499?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:50","pubTimestamp":1786539013,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-genmab-gmab-definitive-healthcare-corp-dh-and-atai-beckley-n-v-atai-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-genmab-gmab-definitive-healthcare-corp-dh-and-atai-beckley-n-v-atai-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4539","GMAB","BK4139","XBI","BK4581","ATAI","BK4007","BK4588","LABU","XLV","BK4167","DH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658970958","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: AIM ImmunoTech (AIM) and Schrodinger (SDGR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658970958","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658970958?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:40","pubTimestamp":1786538419,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on AIM ImmunoTech (AIM) and Schrodinger (SDGR). AIM ImmunoTech (AIM)...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-aim-immunotech-aim-and-schrodinger-sdgr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-aim-immunotech-aim-and-schrodinger-sdgr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","XBI","LABU","BK4137","AIM","BK4167","BK4581","HCSG","LU0128526141.USD","SDGR","XLV","LU0029874061.USD","BK4557","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997785","title":"Analysts Offer Insights on Healthcare Companies: 908 Devices (MASS), Pediatrix Medical Group (MD) and BridgeBio Oncology Therapeutics (BBOT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997785?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:20","pubTimestamp":1786537240,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on 908 Devices (MASS), Pediatrix Medical Group (MD) a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-908-devices-mass-pediatrix-medical-group-md-and-bridgebio-oncology-therapeutics-bbot-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-908-devices-mass-pediatrix-medical-group-md-and-bridgebio-oncology-therapeutics-bbot-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","MASS","XLV","BK4588","BK4585","BK4581","MD","BK4139","LABU","XBI","LU0128526141.USD","BBOT","LU0029874061.USD","BK4157","BK4196","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658990864","title":"Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2658990864","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658990864?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:15","pubTimestamp":1786536900,"startTime":"0","endTime":"0","summary":"Final histology and laboratory analyses support the study’s safety and performance objectives THE WOODLANDS, TX, Aug.  12, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc.(NASDAQ: AMIX) (“Autonomix” o","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/12/3343626/0/en/autonomix-medical-completes-good-laboratory-practice-glp-preclinical-study-marking-key-step-toward-fda-submission.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMIX","BK4590","BK4144","BK4588","LABU","GLP","BK4585","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974286","title":"Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Maze Therapeutics, Inc. (MAZE) and Immunome (IMNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974286?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:40","pubTimestamp":1786534824,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Travere Therapeutics (TVTX), Maze Therapeutics, Inc....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-travere-therapeutics-tvtx-maze-therapeutics-inc-maze-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-travere-therapeutics-tvtx-maze-therapeutics-inc-maze-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","HCSG","BK4588","BK4139","BK4007","LFSC","XLV","MAZE","TVTX","BK4563","XBI","FFTY","BK4581","LU0029874061.USD","IMNM","LU0128526141.USD","BK4137","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974237","title":"TransMedics Buy Rating Reaffirmed as Analyst Maintains $95 Price Target on Robust Multi-Year Growth Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974237","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974237?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:35","pubTimestamp":1786534533,"startTime":"0","endTime":"0","summary":"TransMedics Group, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst William Plovanic from Canaccord Genuity...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/transmedics-buy-rating-reaffirmed-as-analyst-maintains-95-price-target-on-robust-multi-year-growth-outlook-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/transmedics-buy-rating-reaffirmed-as-analyst-maintains-95-price-target-on-robust-multi-year-growth-outlook-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","BK4588","BK4585","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974901","title":"Press Release: PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974901","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974901?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:30","pubTimestamp":1786534200,"startTime":"0","endTime":"0","summary":"-- Completed its New Drug Application  submission to the U.S.Food and Drug Administration  for D-PLEX for the prevention. abdominal colorectal surgery, supported by positive results from. the pivotal Phase 3 SHIELD II trial, which met its primary. endpoint and all key secondary endpoints and demonstrated a 60%. relative risk reduction in SSIs compared to standard of care. -- Subsequent to quarter end, on July 27, 2026, the FDA accepted. D-PLEX NDA submission and granted Priority Review, with a. Prescription Drug User Fee Act  goal date of November 28,communicated first quarter 2027 guidance. The FDA did not identify. any filing review issues in its acceptance communications.-- Exclusive U.S. and Canada Commercialization Partnership with Azurity. -- Following the end of the quarter, on July 17, 2026, PolyPid. entered into a commercial partnership agreement with Azurity. deep experience in specialty and hospital-based therapies with. more than 50 medicines across 10 therapeutic areas. Az","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","TM","BK4099","BK4604","PYPD","BK4007","BK4588","03160","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974863","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Brookdale Senior Living (BKD) and Legend Biotech (LEGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974863","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974863?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:10","pubTimestamp":1786533037,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Brookdale Senior Livi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-brookdale-senior-living-bkd-and-legend-biotech-legn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-brookdale-senior-living-bkd-and-legend-biotech-legn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","BKD","LEGN","BK4532","BK4185","LU1674673691.USD","SG9999001176.USD","TBXU","HCSG","IE00B19Z3581.USD","LABU","LU0061475181.USD","MEDI","GNMX","VERX","LU0432979614.USD","IDNA","LU1778281490.HKD","XLV","BK4588","LU0029874061.USD","SG9999001176.SGD","LU1430594728.SGD","LU1499592464.USD","IBB","MEMS","LU0234570918.USD","LU2089984988.USD","IE0002270589.USD","LU2417539215.USD","IE00B19Z3B42.SGD","BIB","PBE","IE00B894F039.SGD","LU0417517546.SGD","LU0058720904.USD","VRTX","LU2237438978.USD","LU0757428866.USD","XBI","CANC","IE00BZ9MQY76.HKD","LU1035775433.USD","LU2462157665.USD","LU0079474960.USD","LU1585245621.USD","IBBQ","LU1815336091.USD","BK4505","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658044979","title":"Press Release: Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2658044979","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658044979?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:00","pubTimestamp":1786532400,"startTime":"0","endTime":"0","summary":"-- Breakthrough results from V012 dialysis access Phase 3 study, where ATEV was observed to outperform AV fistula; supplemental Biologic License Application (sBLA) for dialysis access to be filed with","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAA","SPRE","AV","CTEV","BK4167","IND","BK4232","LABU","BK4215","BK4563","BK4022","BK4588","R","HUMA","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181412602","title":"Drug Manufacturing Site of Shanghai Haoyuan Chemexpress Passes US FDA Inspection With Zero Deficiencies","url":"https://stock-news.laohu8.com/highlight/detail?id=1181412602","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181412602?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:33","pubTimestamp":1786530782,"startTime":"0","endTime":"0","summary":"Shanghai Haoyuan Chemexpress Co.,Ltd. (688131.SH) announced that its wholly-owned subsidiary, Yaoyuan Biotechnology (Qidong) Co., Ltd., commonly referred to as Yaoyuan Qidong, underwent a...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","688131","BK0216","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658764239","title":"Harmony Biosciences: Strengthening Core Business and Pipeline Support Unchanged $55 Price Target and Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2658764239","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658764239?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:15","pubTimestamp":1786529746,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Holdings, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Patrick Trucchio from H.C. Wainw...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/harmony-biosciences-strengthening-core-business-and-pipeline-support-unchanged-55-price-target-and-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/harmony-biosciences-strengthening-core-business-and-pipeline-support-unchanged-55-price-target-and-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4007","BK4588","LABU","XLV","HRMY","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191884504","title":"Regulatory Milestone: Subsidiary of Aurisco Pharmaceutical Passes U.S. FDA Inspection","url":"https://stock-news.laohu8.com/highlight/detail?id=1191884504","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191884504?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:55","pubTimestamp":1786524918,"startTime":"0","endTime":"0","summary":"Aurisco Pharmaceutical Co.,Ltd. (605116.SH) announced that its wholly-owned subsidiary, Yangzhou Aurisco Pharmaceutical Co., Ltd. (\"Yangzhou Aurisco\"), underwent a cGMP (Current Good Manufacturing...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK0239","LABU","605116","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658297834","title":"LG Electronics Secures US FDA Clearance to Launch New Diagnostic Monitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2658297834","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658297834?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:51","pubTimestamp":1786524669,"startTime":"0","endTime":"0","summary":"LG Electronics  expanded its business-to-business medical device offerings by launching its 40HT513D, a 40-inch curved diagnostic monitor designed for image-based diagnosis in the US, according to a company release on Wednesday.The South Korean consumer electronics company said that the launch comes after the device secured a US Food and Drug Administration clearance as a medical device, The Korea Times reported.The new monitor features a 5,120-by-2,160 resolution, totaling 11 megapixels, allowing users to display multiple images and information simultaneously and can replace three separate 3-megapixel monitors used earlier.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658978453","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Tecan Group AG (OtherTCHBF), Kyverna Therapeutics, Inc. (KYTX) and Pliant Therapeutics (PLRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658978453","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658978453?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:50","pubTimestamp":1786524608,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Tecan Group AG (TCHBF), Kyverna Therapeutics, Inc. (KYTX) and Pli...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-tecan-group-ag-othertchbf-kyverna-therapeutics-inc-kytx-and-pliant-therapeutics-plrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-tecan-group-ag-othertchbf-kyverna-therapeutics-inc-kytx-and-pliant-therapeutics-plrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LABU","SLJY","SLVR","XBI","BK4007","XLV","PLRX","BK4585","HCSG","BK4139","KYTX","AG","SLVX","LU0029874061.USD","BK4588","TCHBF","SILJ","TCGGY","LU0128526141.USD","BK4121","BK4210","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":17,"totalSize":396,"code":"91000000","status":"200"}]}}